16th week of 2021 patent applcation highlights part 9 |
Patent application number | Title | Published |
20210113497 | PHARMACEUTICAL COMPOSITIONS FOR PREVENTING OR TREATING INFLAMMATORY DISEASE, AUTOIMMUNE DISEASE, OR COMBINATION THEREOF, AND METHOD FOR USING SAME | 2021-04-22 |
20210113498 | TOPICAL AND TRANSDERMAL DELIVERY OF AN IRON CHELATOR TO PREVENT AND TREAT CHRONIC WOUNDS | 2021-04-22 |
20210113499 | CERAMIDE MIMICS FOR TREATMENT OF ALZHEIMER'S DISEASE | 2021-04-22 |
20210113500 | COMPOSITION CONTAINING GLIBENCLAMIDE | 2021-04-22 |
20210113501 | METHOD OF ADMINISTERING BETA-HYDROXY-BETA-METHYLBUTYRATE (HMB) | 2021-04-22 |
20210113502 | Threonate Compounds and Methods of Use Thereof | 2021-04-22 |
20210113503 | COMPOSITIONS AND METHODS FOR TREATING CANCER | 2021-04-22 |
20210113504 | ORALLY ADMINISTRABLE MODIFIED-RELEASE PHARMACEUTICAL DOSAGE FORM | 2021-04-22 |
20210113505 | METHODS OF TREATING HAIR RELATED CONDITIONS | 2021-04-22 |
20210113506 | IMMUNOMODULATORY AND DIFFERENTIATING FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS FOR CANCER IMMUNOTHERAPY | 2021-04-22 |
20210113507 | RECEPTOR SUBTYPE AND FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS FOR CANCER IMMUNOTHERAPY | 2021-04-22 |
20210113508 | N-ACETYLCYSTEINE FOR USE AS ANTIBACTERIAL AGENT | 2021-04-22 |
20210113509 | METHODS OF TREATING MIXED DYSLIPIDEMIA | 2021-04-22 |
20210113510 | STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME | 2021-04-22 |
20210113511 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF ACNE | 2021-04-22 |
20210113512 | Methods of Treating Sickle Cell Disease and Related Disorders Using Fumaric Acid Esters | 2021-04-22 |
20210113513 | LOW ERUCTATION COMPOSITION AND METHODS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE IN A SUBJECT WITH FISH ALLERGY/HYPERSENSITIVITY | 2021-04-22 |
20210113514 | AMINOCARBONYLCARBAMATE COMPOUNDS | 2021-04-22 |
20210113515 | PHARMACEUTICAL COMPOSITION, COMPRISING POLMACOXIB AND PREGABALIN, FOR TREATMENT OF PAIN | 2021-04-22 |
20210113516 | PREVENTION AND TREATMENT OF VIRAL INFECTIONS | 2021-04-22 |
20210113517 | Composition for Activating Sympathetic Nerve | 2021-04-22 |
20210113518 | Composition And Use Thereof Against Drugs Induced Phototoxicity | 2021-04-22 |
20210113519 | Compositions and Methods for Modulating Permeability of Biological Barriers | 2021-04-22 |
20210113520 | Novel treatment of mitochondrial diseases | 2021-04-22 |
20210113521 | METHODS OF TREATING PRADER-WILLI SYNDROME | 2021-04-22 |
20210113522 | COUMARIN DERIVATIVE AS ANTI-ASTHMATIC AGENT, PHARMACEUTICAL COMPOSITION THEREOF, ITS PREPARATION AND USE | 2021-04-22 |
20210113523 | Compositions For Treating And/Or Preventing Photodynamic Therapy Side Effects | 2021-04-22 |
20210113524 | METHODS OF TREATING MYELOPROLIFERATIVE DISORDERS | 2021-04-22 |
20210113525 | THERAPEUTIC AGENT FOR AMYOTROPHIC LATERAL SCLEROSIS AND COMPOSITION FOR TREATMENT | 2021-04-22 |
20210113526 | NON-HORMONAL COMPOSITIONS AND METHODS FOR MALE CONTRACEPTION | 2021-04-22 |
20210113527 | PHARMACEUTICAL COMPOSITIONS FOR USE IN THE TREATMENT OF CARDIOVASCULAR CALCIFICATION | 2021-04-22 |
20210113528 | Combination comprising HDAC inhibitor and CD137 agonist for cancer therapy | 2021-04-22 |
20210113529 | MEDICINE FOR PREVENTING OR TREATING OPHTHALMIC DISEASE ASSOCIATED WITH ENHANCED INTRAOCULAR NEOVASCULARIZATION AND/OR INTRAOCULAR VASCULAR PERMEABILITY | 2021-04-22 |
20210113530 | LIQUID FORMULATIONS OF BENDAMUSTINE | 2021-04-22 |
20210113531 | METHODS OF USE FOR TRISUBSTITUTED BENZOTRIAZOLE DERIVATIVES | 2021-04-22 |
20210113532 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | 2021-04-22 |
20210113533 | METHOD OF MODULATING RIBONUCLEOTIDE REDUCTASE | 2021-04-22 |
20210113534 | COMPOUNDS | 2021-04-22 |
20210113535 | MULTIKINASE INHIBITORS OF VEGF AND TGF BETA AND USES THEREOF | 2021-04-22 |
20210113536 | METHODS AND COMPOSITIONS FOR DETECTING AND TREATING VENOUS THROMBOEMBOLISM | 2021-04-22 |
20210113537 | COMBINATION THERAPIES FOR THE TREATMENT OF BREAST CANCER | 2021-04-22 |
20210113538 | Methods and Compositions to Inhibit Adverse Effects Associated with Vaccinations | 2021-04-22 |
20210113539 | COMPOUNDS THAT MODULATES AMPA RECEPTOR FUNCTION | 2021-04-22 |
20210113540 | TREATMENT AGENT AND PHARMACEUTICAL COMPOSITION FOR GLIOMA | 2021-04-22 |
20210113541 | TRANSDERMAL ADMINISTRATION OF FENTANYL AND ANALOGS THEREOF | 2021-04-22 |
20210113542 | METHODS AND COMPOSITIONS FOR SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENTS | 2021-04-22 |
20210113543 | METHODS OF MONITORING, TREATING, AND PREVENTING RENAL INFLAMMATION FOLLOWING CARDIAC PROCEDURES OR EVENTS | 2021-04-22 |
20210113544 | METHODS OF MONITORING, TREATING, AND PREVENTING RENAL INFLAMMATION ASSOCIATED WITH INFECTION | 2021-04-22 |
20210113545 | Pharmaceutical Composition Comprising a Benzoheterocyclic Compound and Androgen Receptor Pathway Modulator and Application Thereof | 2021-04-22 |
20210113546 | NOVEL PEDIATRIC COMBINATION | 2021-04-22 |
20210113547 | METHODS OF TREATMENT FOR CYSTIC FIBROSIS | 2021-04-22 |
20210113548 | METHODS FOR DETERMINING A DRUG DOSING REGIMEN | 2021-04-22 |
20210113549 | TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS | 2021-04-22 |
20210113550 | Specific AKT3 Activator and Uses Thereof | 2021-04-22 |
20210113551 | SUBSTITUTED TETRAHYDROQUINOLINONE COMPOUNDS AS ROR GAMMA MODULATORS | 2021-04-22 |
20210113552 | METHODS FOR ENHANCING CELLULAR CLEARANCE OF PATHOLOGICAL MOLECULES VIA ACTIVATION OF THE CELLULAR PROTEIN YKT6 | 2021-04-22 |
20210113553 | Use of Valbenazine for Treating Schizophrenia or Schizoaffective Disorder | 2021-04-22 |
20210113554 | Nutraceuticals Having Sustained Release for Improved Bioavailability and Method of Production | 2021-04-22 |
20210113555 | COMBINATIONS FOR THE TREATMENT OF CANCER | 2021-04-22 |
20210113556 | Piperazine-Substituted Benzothiophenes For Treatment of Mental Disorders | 2021-04-22 |
20210113557 | METHODS OF TREATING PROSTATE CANCER | 2021-04-22 |
20210113558 | ANTIVIRAL PRODRUGS AND FORMULATIONS THEREOF | 2021-04-22 |
20210113559 | PYRIMIDINE DERIVATIVES AS PGE2 RECEPTOR MODULATORS | 2021-04-22 |
20210113560 | METHOD OF TREATING FIBROTIC DISEASE | 2021-04-22 |
20210113561 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF | 2021-04-22 |
20210113562 | PIM KINASE INHIBITORS FOR TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS AND FIBROSIS ASSOCIATED WITH CANCER | 2021-04-22 |
20210113563 | 4-(4-CYANO-2-THIOARYL)DIHYDROPYRIMIDINONES FOR TREATING CHRONIC WOUNDS | 2021-04-22 |
20210113564 | METHODS FOR TREATING CONGENITAL EPIDERMAL HYPERPLASIA AND COMPOSITIONS FOR SAME | 2021-04-22 |
20210113565 | NEW COMPOUNDS WITH ENHANCED ANTI-TUMOR EFFECTS | 2021-04-22 |
20210113566 | USE OF JAK1 INHIBITORS FOR THE TREATMENT OF CUTANEOUS LUPUS ERYTHEMATOSUS AND LICHEN PLANUS (LP) | 2021-04-22 |
20210113567 | MODIFIED RELEASE FORMULATIONS OF 2-[3-[4-AMINO-3-(2-FLUORO-4-PHENOXY-PHENYL)PYRAZOLO[3,4-D]PYRIMIDIN-1-YL]- PIPERIDINE-1-CARBONYL]-4-METHYL-4-[4-(OXETAN-3-YL)PIPERAZIN-1-YL]PENT-2-EN- ENITRILE | 2021-04-22 |
20210113568 | PREVENTIVE AND/OR THERAPEUTIC AGENT FOR AUTOIMMUNE DISEASE COMPRISING COMPOUND HAVING Btk INHIBITORY ACTIVITY AS ACTIVE INGREDIENT | 2021-04-22 |
20210113569 | Tablet Formulation of 2-Fluoro-N-Methyl-4-[7-(Quinolin-6-Ylmethyl) Imidazo [1,2-B] [1,2,4] Triazin-2-YL] Benzamide | 2021-04-22 |
20210113570 | INHIBITORS OF HIV-1 INTEGRASE MULTIMERIZATION | 2021-04-22 |
20210113571 | PLEUROMUTILIN DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY MICROBES | 2021-04-22 |
20210113572 | Crystalline form of (S)-[2-chloro-4-fluoro-5-(7-morpholin-4-yl-quinazolin-4-yl)phenyl]-(6-met- hoxy-pyridazin-3-yl)-methanol | 2021-04-22 |
20210113573 | COMPOSITIONS AND METHODS TO PROMOTE THYMIC REGENERATION | 2021-04-22 |
20210113574 | METHODS OF TREATING CHRONIC LYMPHOCYTIC LEUKEMIA USING 2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-YL)ME- THYL)BENZYL)AMINO)ISOINDOLINE-1,3-DIONE | 2021-04-22 |
20210113575 | PHARMACEUTICAL COMPOSITIONS COMPRISING (S)-2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-Y- L)METHYL)BENZYL)AMINO)ISOINDOLINE-1,3-DIONE AND METHODS OF USING THE SAME | 2021-04-22 |
20210113576 | SUBSTITUTED 4-AMINOISOINDOLINE-1,3-DIONE COMPOUNDS AND SECOND ACTIVE AGENTS FOR COMBINED USE | 2021-04-22 |
20210113577 | METHODS OF TREATING HEMATOLOGICAL MALIGNANCIES USING 2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-YL)ME- THYL)BENZYL)AMINO)ISOINDOLINE-1,3-DIONE | 2021-04-22 |
20210113578 | QUINAZOLINES AND AZAQUINAZOLINES AS DUAL INHIBITORS OF RAS/RAF/MEK/ERK AND PI3K/AKT/PTEN/MTOR PATHWAYS | 2021-04-22 |
20210113579 | FLUOROQUINOLONE FORMULATIONS FOR CYSTIC FIBROSIS | 2021-04-22 |
20210113580 | NANOPARTICULATE MELOXICAM FORMULATIONS | 2021-04-22 |
20210113581 | METHODS AND COMPOSITIONS RELATING TO LUNG FUNCTION | 2021-04-22 |
20210113582 | PHARMACEUTICAL SOLID PREPARATION COMPRISING BENZAZEPINES AND PRODUCTION METHOD THEREOF | 2021-04-22 |
20210113583 | METHOD AND COMPOUNDS FOR TREATING PERIPHERAL NEUROPATHY | 2021-04-22 |
20210113584 | COMBINATION THERAPY OF TETRACYCLIC QUINOLONE ANALOGS FOR TREATING CANCER | 2021-04-22 |
20210113585 | METHODS FOR TREATING CHOLESTASIS | 2021-04-22 |
20210113586 | NEW USE AND METHODS OF MODULATING IMMUNE RESPONSES | 2021-04-22 |
20210113587 | PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES | 2021-04-22 |
20210113588 | NON-IRRITATING TESTOSTERONE EMULSIONS | 2021-04-22 |
20210113589 | TARGETING NCCA-ATP CHANNEL FOR ORGAN PROTECTION FOLLOWING ISCHEMIC EPISODE | 2021-04-22 |
20210113590 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | 2021-04-22 |
20210113591 | Anesthetic Pharmaceutical Composition, System and Method | 2021-04-22 |
20210113592 | OCULAR IMPLANT MADE BY A DOUBLE EXTRUSION PROCES | 2021-04-22 |
20210113593 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | 2021-04-22 |
20210113594 | TUMOR IMMUNOMODULATOR | 2021-04-22 |
20210113595 | LIPOSOMAL NANO FORMULATION OF COMBINATIONAL ANTIBIOTICS AND THE USES THEREOF | 2021-04-22 |
20210113596 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | 2021-04-22 |